Quest Diagnostics (NYSE:DGX) announced on Wednesday that it will roll out a rapid molecular lab test to detect the avian influenza A H5 virus. This initiative is part of an award from the U.S ...

The Molecular Infectious Disease Testing Market is poised for significant expansion—powered by evolving pathogen landscapes, ...

Researchers in Taiwan and Belgium developed a lab-based diagnostic workflow that could help doctors predict the severity of a ...

The Birmingham, UK, firm hopes to develop a broader test menu with industry partners, using AI and machine-learning approaches.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The Point of Care (PoC) molecular diagnostics market is forecasted to hit USD 5,295 Million by 2025. Then, it is likely to grow to USD 13,733.8 Million by 2035 with a CAGR of 10% over time. Things ...

New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology care iMDx sponsoring GraftAssureIQ™ research-use-only kits at transplant labs globally ...

Formerly known as Oncocyte Corp., Insight Molecular Diagnostics (iMDx) offers diagnostic testing for medical conditions. Nashville is already home to the company's lab, and the offices will operate in ...